High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection

IF 3.7 2区 医学 Q2 IMMUNOLOGY Journal of Microbiology Immunology and Infection Pub Date : 2025-03-17 DOI:10.1016/j.jmii.2025.03.005
Yu-Chang Fu , Ting-wei Lai , Yu-Hua Su , Yu-Chao Lin , Chih-Yen Tu , Chieh-Lung Chen , Po-Ren Hsueh
{"title":"High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection","authors":"Yu-Chang Fu ,&nbsp;Ting-wei Lai ,&nbsp;Yu-Hua Su ,&nbsp;Yu-Chao Lin ,&nbsp;Chih-Yen Tu ,&nbsp;Chieh-Lung Chen ,&nbsp;Po-Ren Hsueh","doi":"10.1016/j.jmii.2025.03.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Emerging evidence highlights that respiratory syncytial virus (RSV) poses a significant risk to older adults. However, detailed clinical data on elderly patients hospitalized with RSV remains limited. This study investigates the clinical characteristics and outcomes of older adults (aged ≥50 years) hospitalized with RSV infection.</div></div><div><h3>Methods</h3><div>This retrospective cohort study included hospitalized patients aged ≥50 years with respiratory symptoms and laboratory-confirmed RSV infection at China Medical University Hospital between January 1, 2011, and December 31, 2023. Data on demographic characteristics and clinical presentations were collected. RSV infection-related outcomes were analyzed across various subgroups.</div></div><div><h3>Results</h3><div>This study included 36 patients, with the most prevalent comorbidities being diabetes mellitus (47.2 %), immunocompromised status (36.1 %), and chronic lung disease (30.6 %). Pneumonia was identified in 72.2 % of patients, while 41.7 % required invasive mechanical ventilation, and the hospital mortality rate was 33.3 %. Non-survivors had higher rates of comorbidities, particularly chronic lung disease (66.7 % vs. 12.5 %, <em>p</em> = 0.002), higher disease severity, elevated procalcitonin levels, and were more likely to develop septic shock and acute respiratory distress syndrome. A bacterial coinfection rate of 33.3 % was observed, with patients experiencing pneumonia or bacterial coinfection showing poorer outcomes. Moreover, patients with chronic lung disease exhibited significantly worse day-28 survival (log-rank <em>p</em> &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>The disease burden of RSV in older adults is amplified by comorbidities such as chronic lung disease, with pneumonia and bacterial coinfections further worsening outcomes. Our findings highlight the need for a more comprehensive understanding and effective preventive strategies to protect this vulnerable population.</div></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"58 4","pages":"Pages 422-428"},"PeriodicalIF":3.7000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Microbiology Immunology and Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1684118225000672","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Emerging evidence highlights that respiratory syncytial virus (RSV) poses a significant risk to older adults. However, detailed clinical data on elderly patients hospitalized with RSV remains limited. This study investigates the clinical characteristics and outcomes of older adults (aged ≥50 years) hospitalized with RSV infection.

Methods

This retrospective cohort study included hospitalized patients aged ≥50 years with respiratory symptoms and laboratory-confirmed RSV infection at China Medical University Hospital between January 1, 2011, and December 31, 2023. Data on demographic characteristics and clinical presentations were collected. RSV infection-related outcomes were analyzed across various subgroups.

Results

This study included 36 patients, with the most prevalent comorbidities being diabetes mellitus (47.2 %), immunocompromised status (36.1 %), and chronic lung disease (30.6 %). Pneumonia was identified in 72.2 % of patients, while 41.7 % required invasive mechanical ventilation, and the hospital mortality rate was 33.3 %. Non-survivors had higher rates of comorbidities, particularly chronic lung disease (66.7 % vs. 12.5 %, p = 0.002), higher disease severity, elevated procalcitonin levels, and were more likely to develop septic shock and acute respiratory distress syndrome. A bacterial coinfection rate of 33.3 % was observed, with patients experiencing pneumonia or bacterial coinfection showing poorer outcomes. Moreover, patients with chronic lung disease exhibited significantly worse day-28 survival (log-rank p < 0.001).

Conclusions

The disease burden of RSV in older adults is amplified by comorbidities such as chronic lung disease, with pneumonia and bacterial coinfections further worsening outcomes. Our findings highlight the need for a more comprehensive understanding and effective preventive strategies to protect this vulnerable population.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在实验室确诊呼吸道合胞病毒感染的住院老年人中,高细菌合并感染率和相关死亡率。
背景:新出现的证据强调呼吸道合胞病毒(RSV)对老年人构成重大风险。然而,关于因呼吸道合胞病毒住院的老年患者的详细临床数据仍然有限。本研究探讨了老年人(≥50岁)因呼吸道合胞病毒感染住院的临床特征和结局。方法:本回顾性队列研究纳入2011年1月1日至2023年12月31日在中国医科大学附属医院住院的年龄≥50岁且伴有呼吸道症状和实验室确诊的呼吸道合胞病毒感染的患者。收集了人口学特征和临床表现的数据。分析不同亚组的RSV感染相关结果。结果:该研究包括36例患者,最常见的合并症是糖尿病(47.2%)、免疫功能低下(36.1%)和慢性肺部疾病(30.6%)。72.2%的患者确诊为肺炎,41.7%的患者需要有创机械通气,医院死亡率为33.3%。非幸存者的合并症发生率更高,特别是慢性肺病(66.7% vs. 12.5%, p = 0.002),疾病严重程度更高,降钙素原水平升高,更有可能发生感染性休克和急性呼吸窘迫综合征。观察到细菌合并感染率为33.3%,出现肺炎或细菌合并感染的患者预后较差。此外,慢性肺病患者的28天生存率明显较差(logrank p)。结论:慢性肺病等合并症放大了老年人RSV的疾病负担,肺炎和细菌共感染进一步恶化了预后。我们的研究结果强调需要更全面的了解和有效的预防策略来保护这一弱势群体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Microbiology Immunology and Infection
Journal of Microbiology Immunology and Infection IMMUNOLOGY-INFECTIOUS DISEASES
CiteScore
15.90
自引率
5.40%
发文量
159
审稿时长
67 days
期刊介绍: Journal of Microbiology Immunology and Infection is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology. Article types considered include perspectives, review articles, original articles, brief reports and correspondence. With the aim of promoting effective and accurate scientific information, an expert panel of referees constitutes the backbone of the peer-review process in evaluating the quality and content of manuscripts submitted for publication.
期刊最新文献
Etiological identification of Orientia tsutsugamushi by metagenomic next-generation sequencing in an adult with septic shock in Taiwan. Characterization of the oral microbiota of Kawasaki disease patients by metagenomic analysis: A pilot study. The implementation of the Infection Control Map-an integrated, visual online information system-enhanced infection control practices and reduced the incidence of multidrug-resistant organisms in a medical intensive care unit. Non-SARS-CoV-2 respiratory tract infections in pediatric populations during the pandemic. Taiwan guideline for the diagnosis and management of juvenile idiopathic arthritis: Consensus statement of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1